Solid Biosciences (SLDB) Profit After Tax Growth (3y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 33.04% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 30.60% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -154.28% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 13.80% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -3.84% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 16.53% |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 47.10% |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - | -23.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.57% |
| Dec 31, 2025 | -48.65% |
| Sep 30, 2025 | -30.90% |
| Jun 30, 2025 | -16.31% |
| Mar 31, 2025 | -15.75% |
| Dec 31, 2024 | -31.79% |
| Sep 30, 2024 | -22.09% |
| Jun 30, 2024 | -10.28% |
| Mar 31, 2024 | -12.87% |
| Dec 31, 2023 | 1.65% |
| Sep 30, 2023 | 0.42% |
| Jun 30, 2023 | -9.06% |
| Mar 31, 2023 | -4.05% |
| Dec 31, 2022 | 21.95% |
| Sep 30, 2022 | 11.31% |
| Jun 30, 2022 | 1.83% |
| Mar 31, 2022 | 5.04% |
| Dec 31, 2021 | 5.31% |
| Sep 30, 2021 | 1.85% |
| Jun 30, 2021 | -1.31% |
| Mar 31, 2021 | -2.10% |
| Dec 31, 2020 | -13.82% |
| Sep 30, 2020 | -16.30% |
| Jun 30, 2020 | -18.85% |
| Mar 31, 2020 | -27.71% |